Coloplast AS (OCSE:COLO B) Debt-to-Asset : 0.51 (As of Jun. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Debt-to-Asset?

Coloplast AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr7,212 Mil. Coloplast AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was kr17,312 Mil. Coloplast AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was kr48,580 Mil. Coloplast AS's debt to asset for the quarter that ended in Jun. 2024 was 0.50.

Coloplast AS Debt-to-Asset Historical Data

The historical data trend for Coloplast AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Debt-to-Asset Chart

Coloplast AS Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Asset

Get a 7-Day Free Trial

0.10

0.13

0.18

0.50

0.41

Coloplast AS Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															0.63	0.41	0.45	0.51	0.51

Competitive Comparison of Coloplast AS's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Coloplast AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Debt-to-Asset falls into.

Coloplast AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Coloplast AS's Debt-to-Asset for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(7345	+	12222)	/	48159
	=	0.41

Coloplast AS's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(7212	+	17312)	/	48580
	=	0.50

Coloplast AS (OCSE:COLO B) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Coloplast AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines